Pub Date : 2025-02-06Epub Date: 2025-01-13DOI: 10.1016/j.intimp.2025.114065
Yuan-Jie Liu, Qing Liu, Jia-Qi Li, Qian-Wen Ye, Sheng-Yan Yin, Cong Liu, Shen-Lin Liu, Xi Zou, Jin Ji
Breslow thickness (BT), a parameter measuring the depth of invasion of abnormally proliferating melanocytes, is a key indicator of melanoma severity and prognosis. However, the mechanisms underlying the increase in BT remain elusive. Utilizing data from The Cancer Genome Atlas (TCGA) human skin cutaneous melanoma (SKCM), we identified a set of BT-related molecules and analyzed their expression and genomic heterogeneity across pan-cancerous and normal tissues. Through consensus clustering, we identified two distinct BT phenotypes in melanoma, which exhibited significant differences in clinical, genomic, and immune infiltration characteristics. High BT molecular expression was associated with reduced CD8+ T cell infiltration and poor immunotherapy response, potentially mediated by the Macrophage Migration Inhibitory Factor (MIF) signaling pathway. In vitro experiments confirmed that BT molecules, including TRIM29, SERPINB5, and RAB25, promoted melanoma development through distinct mechanisms. Notably, fibroblast-derived TRIM29 and B-cell-derived RAB25 interacted with SPP1+ monocytes/macrophages via different pathways. Our findings suggest that genomic variations leading to imbalanced expression of BT molecules across cancers contribute to increased BT, which is closely linked to an immunosuppressive microenvironment. The involvement of multiple cell types and complex intercellular interactions underscores the importance of evaluating dynamic cellular crosstalk in the tumor microenvironment to better understand BT increases and develop more effective immunotherapeutic strategies.
{"title":"Comprehensive Breslow thickness (BT)-based analysis to identify biological mechanisms associated with melanoma pathogenesis.","authors":"Yuan-Jie Liu, Qing Liu, Jia-Qi Li, Qian-Wen Ye, Sheng-Yan Yin, Cong Liu, Shen-Lin Liu, Xi Zou, Jin Ji","doi":"10.1016/j.intimp.2025.114065","DOIUrl":"10.1016/j.intimp.2025.114065","url":null,"abstract":"<p><p>Breslow thickness (BT), a parameter measuring the depth of invasion of abnormally proliferating melanocytes, is a key indicator of melanoma severity and prognosis. However, the mechanisms underlying the increase in BT remain elusive. Utilizing data from The Cancer Genome Atlas (TCGA) human skin cutaneous melanoma (SKCM), we identified a set of BT-related molecules and analyzed their expression and genomic heterogeneity across pan-cancerous and normal tissues. Through consensus clustering, we identified two distinct BT phenotypes in melanoma, which exhibited significant differences in clinical, genomic, and immune infiltration characteristics. High BT molecular expression was associated with reduced CD8+ T cell infiltration and poor immunotherapy response, potentially mediated by the Macrophage Migration Inhibitory Factor (MIF) signaling pathway. In vitro experiments confirmed that BT molecules, including TRIM29, SERPINB5, and RAB25, promoted melanoma development through distinct mechanisms. Notably, fibroblast-derived TRIM29 and B-cell-derived RAB25 interacted with SPP1+ monocytes/macrophages via different pathways. Our findings suggest that genomic variations leading to imbalanced expression of BT molecules across cancers contribute to increased BT, which is closely linked to an immunosuppressive microenvironment. The involvement of multiple cell types and complex intercellular interactions underscores the importance of evaluating dynamic cellular crosstalk in the tumor microenvironment to better understand BT increases and develop more effective immunotherapeutic strategies.</p>","PeriodicalId":13859,"journal":{"name":"International immunopharmacology","volume":"147 ","pages":"114065"},"PeriodicalIF":4.8,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142983353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-06Epub Date: 2025-01-01DOI: 10.1016/j.intimp.2024.113941
Yan Huang, Shuan Dong, Yuan Zhang, Ye Zhang, Yan Guo, Jia Shi, Xiangyun Li, Shasha Liu, Yong Chen, Jianbo Yu
During the process of acute lung injury (ALI) associated with sepsis, the α7nAChR in the cholinergic anti-inflammatory pathway (CAP) plays a crucial role. However, the roles of electroacupuncture (EA) and specialized pro-resolving mediators (SPMs) in this context remain unclear. In this study, we demonstrated that EA activates CAP via α7nAChR, reducing lung permeability and inflammatory cytokine release. Our results highlighted lipoxin A4 (LXA4) as a crucial SPM in this process. EA was shown to enhance LXA4 synthesis and alleviate symptoms in patients with sepsis-related acute respiratory distress syndrome (ARDS). Studies using α7nAChR-deficient mice confirmed its essential role in LXA4 regulation. Macrophages in bronchoalveolar lavage fluid (BALF) were identified as key contributors to the protective effects of LXA4, further supported by experiments involving pulmonary macrophage depletion. In summary, we discovered a novel anti-inflammatory pathway where EA activates α7nAChR, leading to increased LXA4 production and lung protection.
{"title":"Electroacupuncture promotes resolution of inflammation by modulating SPMs via vagus nerve activation in LPS-induced ALI.","authors":"Yan Huang, Shuan Dong, Yuan Zhang, Ye Zhang, Yan Guo, Jia Shi, Xiangyun Li, Shasha Liu, Yong Chen, Jianbo Yu","doi":"10.1016/j.intimp.2024.113941","DOIUrl":"10.1016/j.intimp.2024.113941","url":null,"abstract":"<p><p>During the process of acute lung injury (ALI) associated with sepsis, the α7nAChR in the cholinergic anti-inflammatory pathway (CAP) plays a crucial role. However, the roles of electroacupuncture (EA) and specialized pro-resolving mediators (SPMs) in this context remain unclear. In this study, we demonstrated that EA activates CAP via α7nAChR, reducing lung permeability and inflammatory cytokine release. Our results highlighted lipoxin A4 (LXA4) as a crucial SPM in this process. EA was shown to enhance LXA4 synthesis and alleviate symptoms in patients with sepsis-related acute respiratory distress syndrome (ARDS). Studies using α7nAChR-deficient mice confirmed its essential role in LXA4 regulation. Macrophages in bronchoalveolar lavage fluid (BALF) were identified as key contributors to the protective effects of LXA4, further supported by experiments involving pulmonary macrophage depletion. In summary, we discovered a novel anti-inflammatory pathway where EA activates α7nAChR, leading to increased LXA4 production and lung protection.</p>","PeriodicalId":13859,"journal":{"name":"International immunopharmacology","volume":"147 ","pages":"113941"},"PeriodicalIF":4.8,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142921683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-06Epub Date: 2025-01-05DOI: 10.1016/j.intimp.2024.113954
Xingfu Li, Wei Lu, Linying Ni, Jingyue Su, Daping Wang, Zhenhan Deng
Background: Mitochondrial dysfunction induces chondrocyte senescence, thereby precipitating articular cartilage (AC) degeneration in the pathogenesis of osteoarthritis (OA). Although the transfer of mitochondria from mesenchymal stem cells (MSCs) to host cells and their potential protective role have been demonstrated, whether MSCs can alleviate chondrocyte mitochondrial dysfunction or reverse OA progression remains unclear.
Methods: A mitochondrial tracer was used to investigate the transfer of mitochondria-rich extracellular vesicles (MEV) derived from the culture supernatant of human synovial fluid-derived mesenchymal stem cells (hSF-MSCs). Human articular chondrocytes (hACs) impaired by oxidative stress co-incubated with MEV were used for experimental research in vitro. Healthy hACs and stressed hACs were cultured separately acting as the control groups. The MEV was injected into the OA rats' knee joint serving as experimental group. Healthy and OA rats were served as the control groups. Quantitative reverse transcription polymerase chain reaction (qRT-PCR), western blot (WB), enzyme- linked immunosorbent assay (ELISA), flow cytometry (FC), immunofluorescence (IF), fluorescence spectrophotometer (FS), immunohistochemistry (IHC) and other methods are used to analyze the effect of MEV on hACs and OA progression.
Results: MEV derived from hSF-MSCs could transfer into hACs. Compared to the negative control group, co-incubation with MEV resulted in a significant down-regulation of oxidative stress markers and senescence-associated proteins in hACs, while improved mitochondrial function of hACs. Moreover, the MEV could traverse the dense interstitial layer and migrate towards the deeper cartilage, while intra-articular injection of MEV could effectively attenuate AC degeneration.
Conclusion: The transfer of MEV derived from hSF-MSCs represents a promising strategy for safeguarding AC, thereby offering a potential avenue and mechanism for the treatment of OA.
背景:在骨关节炎(OA)的发病机制中,线粒体功能障碍诱导软骨细胞衰老,从而促使关节软骨(AC)变性。虽然线粒体从间充质干细胞(MSCs)向宿主细胞的转移及其潜在的保护作用已被证实,但MSCs是否能减轻软骨细胞线粒体功能障碍或逆转OA进展仍不清楚。方法:采用线粒体示踪剂研究人滑膜液源性间充质干细胞(hSF-MSCs)培养上清中富含线粒体的细胞外囊泡(MEV)的转移。以氧化应激损伤的人关节软骨细胞(hACs)与MEV共孵育进行体外实验研究。分别培养健康hACs和应激hACs作为对照组。将MEV注射于OA大鼠膝关节内作为实验组。以健康大鼠和OA大鼠为对照组。采用定量逆转录聚合酶链反应(qRT-PCR)、western blot (WB)、酶联免疫吸附试验(ELISA)、流式细胞术(FC)、免疫荧光(IF)、荧光分光光度计(FS)、免疫组织化学(IHC)等方法分析MEV对hACs及OA进展的影响。结果:从hSF-MSCs中获得的MEV可以转移到hACs中。与阴性对照组相比,与MEV共孵育导致hACs中氧化应激标志物和衰老相关蛋白的显著下调,同时改善了hACs的线粒体功能。此外,MEV可以穿过致密的间质层向更深的软骨迁移,而关节内注射MEV可以有效地减弱AC退变。结论:来自hSF-MSCs的MEV转移是一种有希望的保护AC的策略,从而为OA的治疗提供了一种潜在的途径和机制。
{"title":"Mitochondria-rich extracellular vesicles derived from the culture supernatant of human synovial Fluid-derived mesenchymal stem cells Inhibited senescence of Stressed/inflammatory Licensed chondrocytes and Delayed Osteoarthritis progression.","authors":"Xingfu Li, Wei Lu, Linying Ni, Jingyue Su, Daping Wang, Zhenhan Deng","doi":"10.1016/j.intimp.2024.113954","DOIUrl":"10.1016/j.intimp.2024.113954","url":null,"abstract":"<p><strong>Background: </strong>Mitochondrial dysfunction induces chondrocyte senescence, thereby precipitating articular cartilage (AC) degeneration in the pathogenesis of osteoarthritis (OA). Although the transfer of mitochondria from mesenchymal stem cells (MSCs) to host cells and their potential protective role have been demonstrated, whether MSCs can alleviate chondrocyte mitochondrial dysfunction or reverse OA progression remains unclear.</p><p><strong>Methods: </strong>A mitochondrial tracer was used to investigate the transfer of mitochondria-rich extracellular vesicles (MEV) derived from the culture supernatant of human synovial fluid-derived mesenchymal stem cells (hSF-MSCs). Human articular chondrocytes (hACs) impaired by oxidative stress co-incubated with MEV were used for experimental research in vitro. Healthy hACs and stressed hACs were cultured separately acting as the control groups. The MEV was injected into the OA rats' knee joint serving as experimental group. Healthy and OA rats were served as the control groups. Quantitative reverse transcription polymerase chain reaction (qRT-PCR), western blot (WB), enzyme- linked immunosorbent assay (ELISA), flow cytometry (FC), immunofluorescence (IF), fluorescence spectrophotometer (FS), immunohistochemistry (IHC) and other methods are used to analyze the effect of MEV on hACs and OA progression.</p><p><strong>Results: </strong>MEV derived from hSF-MSCs could transfer into hACs. Compared to the negative control group, co-incubation with MEV resulted in a significant down-regulation of oxidative stress markers and senescence-associated proteins in hACs, while improved mitochondrial function of hACs. Moreover, the MEV could traverse the dense interstitial layer and migrate towards the deeper cartilage, while intra-articular injection of MEV could effectively attenuate AC degeneration.</p><p><strong>Conclusion: </strong>The transfer of MEV derived from hSF-MSCs represents a promising strategy for safeguarding AC, thereby offering a potential avenue and mechanism for the treatment of OA.</p>","PeriodicalId":13859,"journal":{"name":"International immunopharmacology","volume":"147 ","pages":"113954"},"PeriodicalIF":4.8,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142931615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-06DOI: 10.1016/j.intimp.2024.114000
Yongsheng Jiang , Jianye Cao , Rui Li , Jia Yu , Yan Peng , Qiong Huang , Wei Zuo , Junyue Chen
<div><h3>Background</h3><div>Peripheral nerve injury (PNI) is a common clinical problem that can result in partial or complete loss of sensory, motor, and autonomic functions. Tetrahydropalmatine (THP), a <em>Corydalis yanhusuo</em>-derived phytochemical alkaloid, possesses hypnotic, soothing, analgesic, and other effects, but little is known about the effect of THP on moderating peripheral nerve regeneration and its possible underlying mechanism of action.</div></div><div><h3>Purpose</h3><div>In this study, we aim to elucidate the protective function of THP on PNI and further reveal the underlying pharmacological mechanisms.</div></div><div><h3>Methods</h3><div>PNI rats were in suit injection of THP solution at doses of 40 mg/kg for consecutive 3, 7, or 28 days, followed by harvesting the sciatic nerve tissues. The protective effect of THP on PNI was evaluated by electrophysiological test, transmission electron microscopy, immunofluorescence (IF), and western blotting (WB). Macrophage polarization, the expression of inflammatory-related genes and cytokines, and its upstream signaling pathways were detected by IF, WB, enzyme-linked immunosorbent assay (ELISA), mRNA-seq, and WB. <em>In vitro</em>, the Raw 264.7 cells were treated with lipopolysaccharide containing with/without THP. The degree of inflammatory activation and its potential pharmacological mechanism were measured by ELISA, qRT-PCR, IF staining, flow cytometry, and WB. Additionally, a pharmacological agonist or inhibitor was added to the cell medium to further identify the role of THP’s potential pharmacological mechanism in regulating inflammatory response via IF and ELISA technology.</div></div><div><h3>Results</h3><div>Using the sciatic nerve crush model, we found that THP significantly enhanced the rate of axonal growth and functional recovery, and altered macrophage subtype transformation from the M1/M0 phenotype into the M2 phenotype, inducing the secretion of large amounts of anti-inflammatory factors. Moreover, THP significantly increased the phosphorylation level of PI3K, AKT, GSK3β, and IκBa, and decreased the expression of TLR4 protein and NF-κB phosphorylation. Similarly, <em>in vitro</em>, THP also facilitated Raw 264.7 cell polarization to the M2 subtype under the condition of LPS stimulation. Meanwhile, the change of PI3K/AKT/GSK3β and TLR4/NF-κB signaling-related proteins <em>in vitro</em> was consistent with the results <em>in vivo</em>. Additionally, the THP-medicated anti-inflammatory effect on Raw 264.7 cells was partly eliminated when pharmacological intervention of these two signaling pathways.</div></div><div><h3>Conclusions</h3><div>THP has anti-inflammatory effects on facilitating M2-subtype macrophage polarization, which produces abundant anti-inflammatory cytokines to ameliorate peripheral nerve regeneration. Moreover, the potential mechanism of THP action may be intimately associated with activating the PI3K/AKT/GSK3β axis and inhibiting the TLR4/NF-κB pathw
{"title":"Tetrahydropalmatine ameliorates peripheral nerve regeneration by enhancing macrophage anti-inflammatory response","authors":"Yongsheng Jiang , Jianye Cao , Rui Li , Jia Yu , Yan Peng , Qiong Huang , Wei Zuo , Junyue Chen","doi":"10.1016/j.intimp.2024.114000","DOIUrl":"10.1016/j.intimp.2024.114000","url":null,"abstract":"<div><h3>Background</h3><div>Peripheral nerve injury (PNI) is a common clinical problem that can result in partial or complete loss of sensory, motor, and autonomic functions. Tetrahydropalmatine (THP), a <em>Corydalis yanhusuo</em>-derived phytochemical alkaloid, possesses hypnotic, soothing, analgesic, and other effects, but little is known about the effect of THP on moderating peripheral nerve regeneration and its possible underlying mechanism of action.</div></div><div><h3>Purpose</h3><div>In this study, we aim to elucidate the protective function of THP on PNI and further reveal the underlying pharmacological mechanisms.</div></div><div><h3>Methods</h3><div>PNI rats were in suit injection of THP solution at doses of 40 mg/kg for consecutive 3, 7, or 28 days, followed by harvesting the sciatic nerve tissues. The protective effect of THP on PNI was evaluated by electrophysiological test, transmission electron microscopy, immunofluorescence (IF), and western blotting (WB). Macrophage polarization, the expression of inflammatory-related genes and cytokines, and its upstream signaling pathways were detected by IF, WB, enzyme-linked immunosorbent assay (ELISA), mRNA-seq, and WB. <em>In vitro</em>, the Raw 264.7 cells were treated with lipopolysaccharide containing with/without THP. The degree of inflammatory activation and its potential pharmacological mechanism were measured by ELISA, qRT-PCR, IF staining, flow cytometry, and WB. Additionally, a pharmacological agonist or inhibitor was added to the cell medium to further identify the role of THP’s potential pharmacological mechanism in regulating inflammatory response via IF and ELISA technology.</div></div><div><h3>Results</h3><div>Using the sciatic nerve crush model, we found that THP significantly enhanced the rate of axonal growth and functional recovery, and altered macrophage subtype transformation from the M1/M0 phenotype into the M2 phenotype, inducing the secretion of large amounts of anti-inflammatory factors. Moreover, THP significantly increased the phosphorylation level of PI3K, AKT, GSK3β, and IκBa, and decreased the expression of TLR4 protein and NF-κB phosphorylation. Similarly, <em>in vitro</em>, THP also facilitated Raw 264.7 cell polarization to the M2 subtype under the condition of LPS stimulation. Meanwhile, the change of PI3K/AKT/GSK3β and TLR4/NF-κB signaling-related proteins <em>in vitro</em> was consistent with the results <em>in vivo</em>. Additionally, the THP-medicated anti-inflammatory effect on Raw 264.7 cells was partly eliminated when pharmacological intervention of these two signaling pathways.</div></div><div><h3>Conclusions</h3><div>THP has anti-inflammatory effects on facilitating M2-subtype macrophage polarization, which produces abundant anti-inflammatory cytokines to ameliorate peripheral nerve regeneration. Moreover, the potential mechanism of THP action may be intimately associated with activating the PI3K/AKT/GSK3β axis and inhibiting the TLR4/NF-κB pathw","PeriodicalId":13859,"journal":{"name":"International immunopharmacology","volume":"147 ","pages":"Article 114000"},"PeriodicalIF":4.8,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143052337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-06DOI: 10.1016/j.intimp.2024.113952
Guoxin Li , Siqi Li , Yilin Jiang , Tao Chen , Zhengwen An
Regulatory T (Treg) cells, immunosuppressive CD4+ T cells, can impede anti-tumor immunity, complicating cancer treatment. Since their discovery, numerous studies have been dedicated to understand Treg cell biology, with a focus on checkpoint pathways’ role in their generation and function. Immune checkpoints, such as PD-1/PD-L1, CTLA-4, TIGIT, TIM-3, and OX40, are pivotal in controlling Treg cell expansion and activity in the tumor microenvironment (TME), affecting their ability to suppress immune responses. This review examines the complex relationship between these checkpoints and Tregs in the TME, and how they influence tumor immunity. We also discuss the therapeutic potential of targeting these checkpoints to enhance anti-tumor immunity, including the use of immune checkpoint blockade (ICB) therapies and novel approaches such as CCR8-targeted therapies. Understanding the interaction between immune checkpoints and Treg cells can lead to more effective immunotherapeutic strategies, such as combining CCR8-targeted therapies with immune checkpoint inhibitors, to improve patient outcomes in cancer treatment.
{"title":"Unleashing the Power of immune Checkpoints: A new strategy for enhancing Treg cells depletion to boost antitumor immunity","authors":"Guoxin Li , Siqi Li , Yilin Jiang , Tao Chen , Zhengwen An","doi":"10.1016/j.intimp.2024.113952","DOIUrl":"10.1016/j.intimp.2024.113952","url":null,"abstract":"<div><div>Regulatory T (Treg) cells, immunosuppressive CD4<sup>+</sup> T cells, can impede anti-tumor immunity, complicating cancer treatment. Since their discovery, numerous studies have been dedicated to understand Treg cell biology, with a focus on checkpoint pathways’ role in their generation and function. Immune checkpoints, such as PD-1/PD-L1, CTLA-4, TIGIT, TIM-3, and OX40, are pivotal in controlling Treg cell expansion and activity in the tumor microenvironment (TME), affecting their ability to suppress immune responses. This review examines the complex relationship between these checkpoints and Tregs in the TME, and how they influence tumor immunity. We also discuss the therapeutic potential of targeting these checkpoints to enhance anti-tumor immunity, including the use of immune checkpoint blockade (ICB) therapies and novel approaches such as CCR8-targeted therapies. Understanding the interaction between immune checkpoints and Treg cells can lead to more effective immunotherapeutic strategies, such as combining CCR8-targeted therapies with immune checkpoint inhibitors, to improve patient outcomes in cancer treatment.</div></div>","PeriodicalId":13859,"journal":{"name":"International immunopharmacology","volume":"147 ","pages":"Article 113952"},"PeriodicalIF":4.8,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143052339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-06DOI: 10.1016/j.intimp.2024.114010
Ziwei Yuan , Shenlei Yu , Dongyan Su , Yuanyuan Gao , Fan Zheng , Penghua Yan , Xuejia Yang , Zujian Hu , Chaosheng Chen , Hong Lu , Yongheng Bai , Shuibing Cheng
Background
Cisplatin-induced acute kidney injury (CKI) represents a severe renal dysfunction characterized by DNA damage and tubular injury. Fraxetin, derived from the Chinese herb Qinpi (Fraxinus bungeana A.DOC), is recognized for its neuroprotective effects and has been used for the prevention of various diseases.
Methods
This study investigated the renoprotective effects and molecular mechanisms of fraxetin in CKI. A mouse CKI model and a cisplatin-induced tubule epithelial cell (TEC) injury model were established to evaluate fraxetin’s effects by measuring diverse parameters associated with kidney injury, focusing on DNA damage and inflammation. Additionally, network pharmacology and cellular sequencing analysis were employed to identify altered pathways or targets after fraxetin treatment. Subsequent experiments involved siRNA and pharmacological regulation to identify fraxetin targets, alongside molecular docking to unravel binding mechanisms.
Results
Fraxetin pretreatment significantly ameliorated CKI, with a 45% reduction in in tubular damage compared to the cisplatin-only group. Additionally, fraxetin notably enhanced DNA repair. Fraxetin pretreatment reduced cisplatin-induced DNA damage in HK-2 cells by 42.8% in comet assays. Fraxetin also mitigated inflammation, with pro-inflammatory cytokine levels decreasing by approximately 20–30% in both mouse and cell models. Notable changes were observed in the FoxO pathway. Specifically, manipulating Forkhead box O1 (FoxO1), a transcription factor involved in stress responses and longevity, influenced fraxetin’s protective effect. Molecular docking revealed that fraxetin binds to the Forkhead (FH) domain of FoxO1, promoting its nuclear localization.
Conclusions
Fraxetin protects against CKI by activating FoxO1, providing a foundation for novel therapeutic strategies and underscoring fraxetin’s potential in treating kidney injury.
背景:顺铂诱导的急性肾损伤(CKI)是一种以 DNA 损伤和肾小管损伤为特征的严重肾功能障碍。从中草药秦皮(Fraxinus bungeana A.DOC)中提取的梣皮素具有神经保护作用,已被用于多种疾病的预防:本研究探讨了梣皮素对 CKI 的肾脏保护作用及其分子机制。建立了小鼠 CKI 模型和顺铂诱导的肾小管上皮细胞(TEC)损伤模型,通过测量与肾损伤相关的各种参数来评估 fraxetin 的作用,重点是 DNA 损伤和炎症。此外,还采用了网络药理学和细胞测序分析,以确定经氟塞汀治疗后发生改变的通路或靶点。随后的实验包括 siRNA 和药理学调控,以确定 fraxetin 的靶点,同时进行分子对接以揭示结合机制:结果:与纯顺铂组相比,氟西汀预处理明显改善了CKI,使肾小管损伤减少了45%。此外,氟西汀还能显著增强 DNA 修复能力。在彗星试验中,Fraxetin 预处理可使 HK-2 细胞中顺铂诱导的 DNA 损伤减少 42.8%。Fraxetin 还能减轻炎症反应,在小鼠和细胞模型中,促炎细胞因子水平都下降了约 20-30%。在 FoxO 通路中观察到了显著的变化。具体来说,Forkhead box O1(FoxO1)是一种参与应激反应和长寿的转录因子,它的操作影响了fraxetin的保护作用。分子对接显示,梣酮能与 FoxO1 的叉头 (FH) 结构域结合,促进其核定位:结论:梣酮素通过激活 FoxO1 防止 CKI,为新的治疗策略提供了基础,并强调了梣酮素治疗肾损伤的潜力。
{"title":"Fraxetin attenuates DNA damage and inflammation in cisplatin-induced nephrotoxicity via FoxO1 activation","authors":"Ziwei Yuan , Shenlei Yu , Dongyan Su , Yuanyuan Gao , Fan Zheng , Penghua Yan , Xuejia Yang , Zujian Hu , Chaosheng Chen , Hong Lu , Yongheng Bai , Shuibing Cheng","doi":"10.1016/j.intimp.2024.114010","DOIUrl":"10.1016/j.intimp.2024.114010","url":null,"abstract":"<div><h3>Background</h3><div>Cisplatin-induced acute kidney injury (CKI) represents a severe renal dysfunction characterized by DNA damage and tubular injury. Fraxetin, derived from the Chinese herb Qinpi (Fraxinus bungeana A.DOC), is recognized for its neuroprotective effects and has been used for the prevention of various diseases.</div></div><div><h3>Methods</h3><div>This study investigated the renoprotective effects and molecular mechanisms of fraxetin in CKI. A mouse CKI model and a cisplatin-induced tubule epithelial cell (TEC) injury model were established to evaluate fraxetin’s effects by measuring diverse parameters associated with kidney injury, focusing on DNA damage and inflammation. Additionally, network pharmacology and cellular sequencing analysis were employed to identify altered pathways or targets after fraxetin treatment. Subsequent experiments involved siRNA and pharmacological regulation to identify fraxetin targets, alongside molecular docking to unravel binding mechanisms.</div></div><div><h3>Results</h3><div>Fraxetin pretreatment significantly ameliorated CKI, with a 45% reduction in in tubular damage compared to the cisplatin-only group. Additionally, fraxetin notably enhanced DNA repair. Fraxetin pretreatment reduced cisplatin-induced DNA damage in HK-2 cells by 42.8% in comet assays. Fraxetin also mitigated inflammation, with pro-inflammatory cytokine levels decreasing by approximately 20–30% in both mouse and cell models. Notable changes were observed in the FoxO pathway. Specifically, manipulating Forkhead box O1 (FoxO1), a transcription factor involved in stress responses and longevity, influenced fraxetin’s protective effect. Molecular docking revealed that fraxetin binds to the Forkhead (FH) domain of FoxO1, promoting its nuclear localization.</div></div><div><h3>Conclusions</h3><div>Fraxetin protects against CKI by activating FoxO1, providing a foundation for novel therapeutic strategies and underscoring fraxetin’s potential in treating kidney injury.</div></div>","PeriodicalId":13859,"journal":{"name":"International immunopharmacology","volume":"147 ","pages":"Article 114010"},"PeriodicalIF":4.8,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143052529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-06DOI: 10.1016/j.intimp.2024.113971
Haoqi Wang , Fei Li , Yuanyuan Feng , Wenqiang Ma , Yuanhao Li , Xueqin Zhao , Jingyi Wu , Chenxi Shi , Lu Zong , Jing Li , Jingjing Cong , Xuefu Wang
Chimeric antigen receptor T (CAR-T) cells represent a promising approach for cancer immunotherapy, yet their efficacy is hindered by immunosuppressive signals in the tumor microenvironment. Casitas B-cell lymphoma protein b (Cbl-b) is a key negative regulator of T cell function. This study investigated whether inhibiting Cbl-b enhances the antitumor activity of human CAR-T cells. The Cbl-b inhibitor NX-1607 was shown to significantly improve CAR-T cell production and function. When applied during the manufacturing phase, NX-1607 increased the yield of anti-CD19 CAR-T cells. Treatment during the expansion phase enhanced cytokine secretion and cytotoxic activity. Notably, continuous NX-1607 treatment throughout manufacturing and expansion maximized CAR-T cell yield, cytokine production, and cytotoxicity. In vivo, NX-1607-treated CAR-T cells exhibited superior efficacy against hematological malignancies. These findings highlight Cbl-b as a therapeutic target for enhancing CAR-T cell manufacturing efficiency and antitumor efficacy, underscoring its potential for clinical applications.
{"title":"Cbl-b inhibition improves manufacturing efficiency and antitumoral efficacy of anti-CD19 CAR-T cells","authors":"Haoqi Wang , Fei Li , Yuanyuan Feng , Wenqiang Ma , Yuanhao Li , Xueqin Zhao , Jingyi Wu , Chenxi Shi , Lu Zong , Jing Li , Jingjing Cong , Xuefu Wang","doi":"10.1016/j.intimp.2024.113971","DOIUrl":"10.1016/j.intimp.2024.113971","url":null,"abstract":"<div><div>Chimeric antigen receptor T (CAR-T) cells represent a promising approach for cancer immunotherapy, yet their efficacy is hindered by immunosuppressive signals in the tumor microenvironment. Casitas B-cell lymphoma protein b (Cbl-b) is a key negative regulator of T cell function. This study investigated whether inhibiting Cbl-b enhances the antitumor activity of human CAR-T cells. The Cbl-b inhibitor NX-1607 was shown to significantly improve CAR-T cell production and function. When applied during the manufacturing phase, NX-1607 increased the yield of anti-CD19 CAR-T cells. Treatment during the expansion phase enhanced cytokine secretion and cytotoxic activity. Notably, continuous NX-1607 treatment throughout manufacturing and expansion maximized CAR-T cell yield, cytokine production, and cytotoxicity. In vivo, NX-1607-treated CAR-T cells exhibited superior efficacy against hematological malignancies. These findings highlight Cbl-b as a therapeutic target for enhancing CAR-T cell manufacturing efficiency and antitumor efficacy, underscoring its potential for clinical applications.</div></div>","PeriodicalId":13859,"journal":{"name":"International immunopharmacology","volume":"147 ","pages":"Article 113971"},"PeriodicalIF":4.8,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142927127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-06DOI: 10.1016/j.intimp.2024.113967
Salvatore Chirumbolo , Marianno Franzini , Luigi Valdenassi
The action of ozone in medicine is a subject of interest and lively, controversial debates. Its mechanisms of action are still far from fully understood. However, it is possible that ozone triggers a series of dynamics in living organisms related to chaos, multi-stable phenomena, and oscillatory processes. Ozone may be involved in adaptive chaos. Adaptive chaos in health and the reduction of complexity in pathology are interconnected phenomena that describe the functional dynamics of biological systems. Adaptive chaos refers to a state of controlled, complex, and flexible behaviour exhibited by healthy biological systems. It allows for a dynamic balance between order and unpredictability, enabling the system to respond to various internal and external stimuli. In pathological states, the system loses its adaptive chaos, often becoming either too rigid or overly chaotic. This reduction in complexity limits the ability of the system to respond effectively to stimuli, making it prone to dysfunction. This paper addresses the role of ozone in these scenarios.
{"title":"About the ozone ability in using adaptive chaos to restore a healthy state in the oxygen-ozone adjunct therapy","authors":"Salvatore Chirumbolo , Marianno Franzini , Luigi Valdenassi","doi":"10.1016/j.intimp.2024.113967","DOIUrl":"10.1016/j.intimp.2024.113967","url":null,"abstract":"<div><div>The action of ozone in medicine is a subject of interest and lively, controversial debates. Its mechanisms of action are still far from fully understood. However, it is possible that ozone triggers a series of dynamics in living organisms related to chaos, multi-stable phenomena, and oscillatory processes. Ozone may be involved in adaptive chaos. Adaptive chaos in health and the reduction of complexity in pathology are interconnected phenomena that describe the functional dynamics of biological systems. Adaptive chaos refers to a state of controlled, complex, and flexible behaviour exhibited by healthy biological systems. It allows for a dynamic balance between order and unpredictability, enabling the system to respond to various internal and external stimuli. In pathological states, the system loses its adaptive chaos, often becoming either too rigid or overly chaotic. This reduction in complexity limits the ability of the system to respond effectively to stimuli, making it prone to dysfunction. This paper addresses the role of ozone in these scenarios.</div></div>","PeriodicalId":13859,"journal":{"name":"International immunopharmacology","volume":"147 ","pages":"Article 113967"},"PeriodicalIF":4.8,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142908860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-06DOI: 10.1016/j.intimp.2024.114008
Jun Pei , Huali Weng , Jinpu Peng , Moudong Wu , Xiong Zhan , Guohua Zhu , Dan Wang , Xingyu Pan , Nini An
Background
Neutrophil extracellular traps (NETs) have been found to promote inflammatory responses and exacerbate tissue damage, as well as to be strongly associated with the development of acute rejection in kidney transplantation. Taking measures against NETs is important for the treatment of acute rejection in kidney transplantation.
Methods
We used the kidney ransplantation acute rejection dataset GSE50058 as a basis for identifying biomarkers associated with the regulation of NETs therein and constructing a diagnostic model using WGCNA and four machine learning algorithms. We also explored the infiltration levels of 64 immune cells and the correlation between NETs-related biomarkers and immune cells in acute rejection of kidney transplants using the xCell algorithm. Meanwhile, we established a rat kidney ransplantation acute rejection model and validated the expression of biomarkers in animal experiments. Finally, we also explored the role of one of the biomarkers in the regulation of NETs by injecting adeno-associated viruses into the tail vein of rats.
Results
In this study, we identified a total of four NETs-associated biomarkers in acute rejection of kidney transplantation: GPX3, B2M, CDK1 and MAP3K5. Among them, the expression of GPX3 was negatively correlated with acute rejection of kidney transplantation, while the remaining three markers were positively correlated with acute rejection. We constructed a diagnostic model based on the above four biomarkers, and both the ROC curve and the calibration curve proved the good diagnostic value of the model, and the DCA curve confirmed the clinical decision-making ability of the four biomarkers. The xCell algorithm identified 20 types of immune cells with significantly altered infiltration levels in acute rejection of kidney transplants, and the expression of four biomarkers was strongly associated with multiple immune cells. In animal experiments, the expression levels of the four biomarkers were consistent with the results analyzed in the dataset GSE50058. Finally, we also found through animal experiments that overexpression of GPX3 could inhibit the activation of NETs in renal tissues and reduce the secretion of inflammatory factors, thereby alleviating renal tissue injury caused by acute rejection of kidney transplantation.
Conclusion
GPX3, B2M, CDK1 and MAP3K5 as biomarkers associated with NETs in acute rejection of kidney transplantation. Among them, GPX3 can inhibit the activation of NETs and reduce the expression of inflammatory factors in the acute rejection of kidney transplantation, thus alleviating renal tissue injury.
{"title":"Identification of potential targets regulating neutrophil extracellular traps in acute rejection of kidney transplantation based on transcriptomics and animal experiments","authors":"Jun Pei , Huali Weng , Jinpu Peng , Moudong Wu , Xiong Zhan , Guohua Zhu , Dan Wang , Xingyu Pan , Nini An","doi":"10.1016/j.intimp.2024.114008","DOIUrl":"10.1016/j.intimp.2024.114008","url":null,"abstract":"<div><h3>Background</h3><div>Neutrophil extracellular traps (NETs) have been found to promote inflammatory responses and exacerbate tissue damage, as well as to be strongly associated with the development of acute rejection in kidney transplantation. Taking measures against NETs is important for the treatment of acute rejection in kidney transplantation.</div></div><div><h3>Methods</h3><div>We used the kidney ransplantation acute rejection dataset GSE50058 as a basis for identifying biomarkers associated with the regulation of NETs therein and constructing a diagnostic model using WGCNA and four machine learning algorithms. We also explored the infiltration levels of 64 immune cells and the correlation between NETs-related biomarkers and immune cells in acute rejection of kidney transplants using the xCell algorithm. Meanwhile, we established a rat kidney ransplantation acute rejection model and validated the expression of biomarkers in animal experiments. Finally, we also explored the role of one of the biomarkers in the regulation of NETs by injecting adeno-associated viruses into the tail vein of rats.</div></div><div><h3>Results</h3><div>In this study, we identified a total of four NETs-associated biomarkers in acute rejection of kidney transplantation: GPX3, B2M, CDK1 and MAP3K5. Among them, the expression of GPX3 was negatively correlated with acute rejection of kidney transplantation, while the remaining three markers were positively correlated with acute rejection. We constructed a diagnostic model based on the above four biomarkers, and both the ROC curve and the calibration curve proved the good diagnostic value of the model, and the DCA curve confirmed the clinical decision-making ability of the four biomarkers. The xCell algorithm identified 20 types of immune cells with significantly altered infiltration levels in acute rejection of kidney transplants, and the expression of four biomarkers was strongly associated with multiple immune cells. In animal experiments, the expression levels of the four biomarkers were consistent with the results analyzed in the dataset GSE50058. Finally, we also found through animal experiments that overexpression of GPX3 could inhibit the activation of NETs in renal tissues and reduce the secretion of inflammatory factors, thereby alleviating renal tissue injury caused by acute rejection of kidney transplantation.</div></div><div><h3>Conclusion</h3><div>GPX3, B2M, CDK1 and MAP3K5 as biomarkers associated with NETs in acute rejection of kidney transplantation. Among them, GPX3 can inhibit the activation of NETs and reduce the expression of inflammatory factors in the acute rejection of kidney transplantation, thus alleviating renal tissue injury.</div></div>","PeriodicalId":13859,"journal":{"name":"International immunopharmacology","volume":"147 ","pages":"Article 114008"},"PeriodicalIF":4.8,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142931608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}